Can immune cells from belly fluid fight advanced cancer?
NCT ID NCT07378436
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests a new treatment called GK02 for people with advanced solid tumors that cause fluid buildup in the belly (malignant ascites). The treatment uses the patient's own immune cells taken from that fluid, grown in a lab, and then given back. Only 9 participants will be enrolled to check safety and see if it helps control the fluid or the cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tumor-reactive T cells (GK02) taken from the patient's own ascites fluid
- What this could lead to
- If it works, this could point toward a new way to control malignant ascites and slow tumor growth in advanced cancers.
- What could go wrong
- This is a very early, tiny trial (9 people) focused on safety. The treatment may not shrink tumors or improve survival, and side effects could be serious.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT ASCITES CAUSED BY ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing GoBroad Hospital
RECRUITINGBeijing, China